Association of serum proprotein convertase Subtilisin/Kexin Type 9 (PCSK9) level with thyroid function disorders

Yildirim, A.; Koca, A.; Beyan, E.; Dogan, ÖZLEM; Karakaya, S.; Aksoz, Z.; Ertugrul, D.

doi:10.26355/eurrev_202109_26662

Association of serum proprotein convertase Subtilisin/Kexin Type 9 (PCSK9) level with thyroid function disorders

Yildirim A. M., Koca A. O., Beyan E., Dogan Ö., Karakaya S., Aksoz Z., ...Daha Fazla

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, cilt.25, sa.17, ss.5511-5517, 2021 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 25 Sayı: 17
Basım Tarihi: 2021
Doi Numarası: 10.26355/eurrev_202109_26662
Dergi Adı: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
Sayfa Sayıları: ss.5511-5517
Anahtar Kelimeler: PCSK9, TSH, Thyroid dysfunction, PLASMA PCSK9, CHOLESTEROL, METABOLISM, BINDING
Ankara Üniversitesi Adresli: Evet

Özet

OBJECTIVE: We aimed at demonstrating the effect of thyroid function status on proprotein convertase subtilisin kexin type 9 (PCSK9) and determining the effect of thyroid hormones on lipid metabolism by comparing the PCSK9 levels of patients with subclinical hypothyroidism, overt hypothyroidism, and hyperthyroidism.